Difference between revisions of "Ovarian cancer epidemiology and demographics"

Jump to: navigation, search
(Prevalence)
 
Line 8: Line 8:
 
==Epidemiology and Demographics==
 
==Epidemiology and Demographics==
 
===Prevalence===
 
===Prevalence===
*[[Ovarian cancer]] is more common in industrialized nations, with the exception of Japan. In the [[United States]], females have a 1.4% to 2.5% (1 out of 40-60 women) lifetime chance of developing [[ovarian cancer]].
+
*[[Ovarian cancer]] is more common in industrialized nations, with the exception of Japan. In the [[United States]], females have a 1.4% to 2.5% (1 out of 40-60 women) lifetime chance of developing [[ovarian cancer]].<ref name="Brett M.Brett M.2017">{{cite journal|last1=Brett M.|first1=Reid|last2=Brett M.|first2=Reid|last3=Jennifer B.|first3=Permuth|last4=Thomas A.|first4=Sellers|last5=Jennifer B.|first5=Permuth|last6=Thomas A.|first6=Sellers|title=Epidemiology of ovarian cancer: a review|journal=Cancer Biology & Medicine|volume=14|issue=1|year=2017|pages=9–32|issn=2095-3941|doi=10.20892/j.issn.2095-3941.2016.0084}}</ref>
 
+
*In the United States, the age-adjusted [[prevalence]] of [[ovarian cancer]] is 71.3 per 100,000 in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
* In the United States, the age-adjusted [[prevalence]] of [[ovarian cancer]] is 71.3 per 100,000 in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 
  
 
===Incidence===
 
===Incidence===

Latest revision as of 16:12, 13 September 2019

Ovarian cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classifications

Pathophysiology

Causes of Ovarian cancer

Differentiating Ovarian cancer from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian cancer epidemiology and demographics

CDC on Ovarian cancer epidemiology and demographics

Ovarian cancer epidemiology and demographics in the news

Blogs on Ovarian cancer epidemiology and demographics

Directions to Hospitals Treating Ovarian cancer

Risk calculators and risk factors for Ovarian cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2] Huda A. Karman, M.D.

Overview

Ovarian cancer is the 7th most common type of cancer in women worldwide[1] and the 8th most common type of cancer in the United States.[2] Ovarian cancer is the second most common gynecologic malignancy and the most common cause of gynecologic cancer death in the United States. Ovarian cancer is the second most common gynecologic malignancy in developed countries, with an incidence of 9.4 per 100,000 women and a mortality rate of 5.1 per 100,000. In developing countries, it is the third most common gynecologic malignancy (cervical cancer is the most common), with an incidence of 5.0 per 100,000 and a mortality rate of 3.1 per 100,000. The age-adjusted prevalence of ovarian cancer in the United States is 71.3 per 100,000 in 2011.[3] The estimated number of new cases of ovarian cancer is approximately 22,000.[4]

Epidemiology and Demographics

Prevalence

Incidence

Age

  • Older women are at highest risk. More than half of the deaths from ovarian cancer occur in women between 55 and 74 years of age.

Delay-adjusted incidence and observed incidence of ovarian cancer by age and race in the United States between 1975 and 2011

Race

  • Shown below is a table depicting the age-adjusted prevalence of ovarian cancer by race in 2011 in the United States.[3]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 71.3 per 100,000 76.2 per 100,000 44.2 per 100,000 63.2 per 100,000 59.1 per 100,000

Incidence of ovarian cancer by race in the United States between 1975 and 2011

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

Percent Distribution of Ovarian Cancer by Histology

Among patients with histologically confirmed cases of ovarian cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:[3]

  • Carcinoma: 91.7%
    • Epidermoid carcinoma: 0.7%
    • Adenocarcinoma: 84%
      • Adenocarcinoma, not otherwise specified: 12.3%
      • Papillary adenocarcinoma: 1,5%
      • Clear cell adenocarcinoma: 5.2%
      • Endometrioid carcinoma: 9.7%
      • Cystadenocarcinoma, not otherwise specified: 0.4%
      • Serous cystadenocarcinoma: 20.9%
      • Papillary serous cystadenocarcinoma: 23.5%
      • Mucinous cystadenocarcinoma: 1.5%
      • Mucinous adenocarcinoma: 3.5%
      • Mucin-producing adenocarcinoma: 0.2%
      • Other adenocarcinoma: 5.3%
    • Other specific carcinoma: 2.3%
      • Stromal cell tumor: 1.6%
      • Other: 0.7%
    • Unspecified carcinoma, not otherwise specified: 4.6%
  • Sarcoma and other soft tissues: 0.4%
  • Other specific types: 6.9%
    • Mullerian mixed tumor: 3%
    • Malignant teratoma: 1.5%
    • Other: 2.4%
  • Unspecified: 1.1%

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

References

  1. Ovarian cancer incidence statistics. Cancer research UK
  2. [www.cdc.gov/cancer/ovarian/statistics/ Ovarian cancer statistics. Cdc.gov]
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  4. Siegel R, Ma J, Zou Z, Jemal A (2014). "Cancer statistics, 2014". CA Cancer J Clin. 64 (1): 9–29. doi:10.3322/caac.21208. PMID 24399786.
  5. Brett M., Reid; Brett M., Reid; Jennifer B., Permuth; Thomas A., Sellers; Jennifer B., Permuth; Thomas A., Sellers (2017). "Epidemiology of ovarian cancer: a review". Cancer Biology & Medicine. 14 (1): 9–32. doi:10.20892/j.issn.2095-3941.2016.0084. ISSN 2095-3941.

Linked-in.jpg